Quick Answer
Profound Medical Corp. reported Research And Development Expense of $20.60 million for the year ending 2025.
- Profound Medical Corp. showed an increase of +21.4% in Research And Development Expense from 2024 to 2025.
- This data is from Profound Medical Corp.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Profound Medical Corp.'s Research And Development Expense has grown by 42.8%.
- Historical annual values: Fiscal year 2025: $20.60 million | Fiscal year 2024: $16.97 million | Fiscal year 2023: $14.42 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: